517 MYLAN (Gemfibrozil 600 mg)
Pill imprint 517 MYLAN has been identified as Gemfibrozil 600 mg.
Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 517 MYLAN
- Strength:
- 600 mg
- Color:
- White
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
More about gemfibrozil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 16 Reviews – Add your own review/rating
- Drug class: fibric acid derivatives
Consumer resources
Other brands: Lopid
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
